Meeder Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.2K | Sell |
|
|||||
|
2025
Q1 | $229K | Sell |
|
|||||
|
2024
Q4 | $247K | Buy |
|
|||||
|
2024
Q3 | $89.4K | Hold |
|
|||||
|
2024
Q2 | $69.7K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $409 | Sell |
|
|||||
|
2022
Q3 | $1K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $99K | Hold |
|
|||||
|
2021
Q2 | $107K | Hold |
|
|||||
|
2021
Q1 | $85K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $55K | Hold |
|
|||||
|
2020
Q2 | $86K | Buy |
|
|||||
|
2020
Q1 | $52K | Buy |
|
|||||
|
2019
Q4 | $25K | Buy |
|
|||||
|
2019
Q3 | $19K | Sell |
|
|||||
|
2019
Q2 | $50K | Buy |
|
|||||
|
2019
Q1 | $9K | Sell |
|
|||||
|
2018
Q4 | $67K | Buy |
|
|||||
|
2018
Q3 | $46K | Sell |
|
|||||
|
2018
Q2 | $51.5K | Buy |
|
|||||
|
2018
Q1 | $5K | Buy |
|
|||||
|
2017
Q4 | $3K | Buy |
|